Cleveland, OHNCT07166939Now EnrollingIRB Ready

Asthma Acute Clinical Trial in Cleveland, OH

Access cutting-edge asthma acute treatment through this clinical trial at a research site in Cleveland. Study-provided care at no cost to qualified participants.

Sponsored by Massachusetts General Hospital

Quick Self-Assessment

See if you qualify for this Cleveland location

Preparing your pre-screening questions…

Expert Care in Cleveland

Access asthma acute specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related asthma acute treatment provided free

Apply for This Cleveland Location

Check if you qualify for this asthma acute clinical trial in Cleveland, OH

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Cleveland

    Convenient for OH residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Cleveland site if eligible
  4. 4Begin participation

About This Asthma Acute Study in Cleveland

The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).

Sponsor: Massachusetts General Hospital

Who Can Participate

Inclusion Criteria

acute asthma
age 18.0 to 54.9 years
English and/or Spanish speaking
decision by ED attending to discharge patient to home on short course of systemic corticosteroids
(intervention group only) Willingness to use Airsupra as their rescue inhaler for next 3 months
demonstration of acceptable MDI administration technique
provision of informed consent prior to any study-specific procedures

Exclusion Criteria

involvement in the planning and/or conduct of the study
previous enrolment in the present study
prior diagnosis of COPD, chronic bronchitis, or emphysema
use of systemic corticosteroids in the past 2 weeks
participation in another clinical study with an investigational product during the past 4 weeks or the 3 months after enrollment in the current study
concurrent pneumonia
clinically significant cardiovascular disease or clinically significant cancer
patients with known hypersensitivity to Airsupra, albuterol sulfate, budesonide, or any of the excipients of the product
(for women only, by self-report):
currently pregnant
currently breastfeeding,
(among sexually active women of child-bearing age only) not using adequate contraception over the last 3 months, or no plan to use adequate contraception over the next 3 months
lack of a working cell phone and working email address
expected lack of availability for text and/or telephone follow-up at approximately 3, 6, and 12 weeks after the ED visit
inability to provide an alternate contact with a working cell phone and working email address.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Cleveland?

Yes, this clinical trial (NCT07166939) has an active research site in Cleveland, OH that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Asthma Acute Treatment Options in Cleveland, OH

If you're searching for asthma acute treatment options in Cleveland, OH, this clinical trial (NCT07166939) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Cleveland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced asthma acute specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all asthma acute clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Cleveland, OH

See all ankylosing spondylitis clinical trials recruiting in Cleveland — not just this study.

Browse Ankylosing Spondylitis Trials in Cleveland →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsAll Conditions →

Ready to Join in Cleveland?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Cleveland, OH